Neuberger Berman Group LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$208,000
-1.4%
8,0850.0%0.00%
Q2 2021$211,000
-63.2%
8,085
-50.2%
0.00%
-100.0%
Q1 2021$574,000
+33.2%
16,246
-3.3%
0.00%
Q4 2020$431,000
-29.7%
16,801
+5.6%
0.00%
-100.0%
Q3 2020$613,000
+0.5%
15,910
+11.6%
0.00%0.0%
Q2 2020$610,000
+130.2%
14,260
+4.9%
0.00%
Q1 2020$265,00013,6000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders